Stock listing

SIX Swiss:ROP Roche Holding Ltd Aktie

Swiss listing (SIX Swiss) of Roche Holding Ltd · home listing SIX Swiss:RO

Follow Roche Holding Ltd into a list and get an email when it puts out news.

Share price · SIX:ROP

399.00 CHF +8.10 (+2.1%)

Close on Oct 27, 2026

Day range
393.10 – 399.00 CHFOct 27, 2026
Volume
1.01M sharesOct 27, 2026
Market cap
317.9B CHFAt the close on Oct 27, 2026 · price × 796.8M shares outstanding
Roche Holding Ltd logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
SIX Swiss:RO · Home411.20 CHF+1.80 (+0.4%)32,339415.00415.60409.80409.40Close on Oct 30, 2026
SIX Swiss:ROP399.00 CHF+8.10 (+2.1%)1,010,114395.90399.00393.10390.90Close on Oct 27, 2026
OTC:RHHBY$60.31 USD-0.86 (-1.4%)476,571$59.42$60.37$59.42$61.17Close on Oct 27, 2026
OTC:RHHVF$480.61 USD-4.39 (-0.9%)2,100$479.83$485.95$470.23$485.00Close on Oct 27, 2026
OTC:RHHBF$474.90 USD-17.91 (-3.6%)—$474.90$474.90$474.90$492.81Close on Oct 27, 2026
LSE:0QQ6404.80 CHF+5.60 (+1.4%)486404.60405.80400.60399.20Close on Oct 27, 2026
TSX:ROG$31.51 CAD+0.38 (+1.2%)600$31.37$31.78$31.37$31.13Close on Oct 27, 2026
Cboe Canada:ROCH$14.96 CAD+0.28 (+1.9%)800$14.78$14.96$14.78$14.68Close on Oct 27, 2026
Frankfurt:RHO€435.80 EUR+3.20 (+0.7%)—€433.00€439.20€433.00€432.60Close on Oct 27, 2026
LSE:0TDF$60.24 USD-0.16 (-0.3%)29$59.75$60.24$59.51$60.40Close on Oct 27, 2026
Dusseldorf:RHO€443.20 EUR+8.60 (+2.0%)—€443.20€443.20€443.20€434.60Close on Oct 30, 2026
Frankfurt:RHO6€54.03 EUR+0.18 (+0.3%)—€54.03€54.03€54.03€53.85Close on Oct 30, 2026
Ticker
SIX Swiss:ROP
Asset type
Stock
Sector
Health care
Industry
Pharmaceuticals
Exchange
SIX Swiss
Currency
CHF

What changed lately

Calls

Replays

  • Roche Holding (SIX Swiss: RO) Q3 2026 Earnings Call

    Thu, Oct 22, 2026 · 8:00 AM ET

    Watch Transcript

  • Roche Holding (SIX Swiss: RO) Q2 2026 Earnings Call

    Thu, Jul 23, 2026 · 8:00 AM ET

    Watch Transcript

  • Roche Holding (SIX Swiss: RO) Q1 2026 Earnings Call

    Thu, Apr 23, 2026 · 8:00 AM ET

    Watch Transcript

Latest news

Genentech Presents New Data at EURETINA, Highlighting Vabysmo’s Real-World Effectiveness and Safety Across Major Retinal Conditions

Oct 1, 2026

Roche fenebrutinib is the first BTK inhibitor to receive U.S. FDA filing acceptance in both relapsing and primary progressive multiple sclerosis

Sep 30, 2026

Roche launches newborn screening test for three severe genetic conditions

Sep 30, 2026

Genentech Breaks Ground on $750 Million Manufacturing Expansion in Hillsboro, Oregon

Sep 28, 2026

Positive Interim Data Shows Genentech’s Sefaxersen Significantly Reduces Proteinuria in People With IgA Nephropathy (IgAN)

Sep 23, 2026

Genentech Announces Positive Phase II Results for Dual GLP-1/GIP Receptor Agonist Enicepatide in People Living With Type 2 Diabetes and Overweight or Obesity

Sep 22, 2026

European Commission approves Roche’s Susvimo® for the treatment of neovascular age-related macular degeneration (nAMD)

Sep 21, 2026

CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis

Sep 18, 2026

Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center

Sep 17, 2026

Genentech’s Lunsumio-Based Regimen Significantly Improves Progression-Free Survival in Follicular Lymphoma in Phase III CELESTIMO Study

Sep 17, 2026

All Roche Holding Ltd news

Decks

Roche Holding Ltd on 6ix

Sector
Health care
Industry
Pharmaceuticals
News releases
93 in the last 12 months · 123 in all · newest Oct 1, 2026 · oldest 2025
Calls
24 calls with a replay · 24 with a transcript · latest Oct 22, 2026
Decks
261 decks · latest Oct 22, 2026

Where Roche Holding Ltd is listed

ListingExchangeCountryCurrency
SIX Swiss:RO · Home listingSIX SwissSwitzerlandCHF
SIX Swiss:ROP · This pageSIX SwissSwitzerlandCHF
OTC:RHHBYOTCUnited StatesUSD
Xetra:RHOXetraGermanyEUR
OTC:RHHVFOTCUnited StatesUSD
Milan:1ROMilanItalyEUR
gettex:RHOgettexGermanyEUR
OTC:RHHBFOTCUnited StatesUSD
LSIN:0QOKLSINUnited KingdomCHF
LSE:0QQ6LSEUnited KingdomCHF
BX Swiss:ROPBX SwissSwitzerlandCHF
VIE:ROGHViennaAustriaEUR
TSX:ROGTSXCanadaCAD
Milan:1ROGMilanItalyEUR
Tradegate:RHOTradegateGermanyEUR
Cboe Canada:ROCHCboe CanadaCanadaCAD
gettex:RHO6gettexGermanyEUR
BIVA:ROGNBIVAMexicoMXN
Frankfurt:RHOFrankfurtGermanyEUR
BMV:ROGNBMVMexicoMXN
LS Exchange:851311LS ExchangeGermanyEUR
Cboe Canada:ROGCboe CanadaCanadaCAD
gettex:RHOAgettexGermanyEUR
LSE:0TDFLSEUnited KingdomUSD
Aquis:ROPZAquisUnited KingdomCHF
Tradegate:RHO6TradegateGermanyEUR
Aquis:ROZAquisUnited KingdomCHF
Lang & Schwarz:851311Lang & SchwarzGermanyEUR
Tradegate:RHOATradegateGermanyEUR
Lang & Schwarz:A424UKLang & SchwarzGermanyEUR
BX Swiss:RHOBX SwissSwitzerlandCHF
Stuttgart:RHO6StuttgartGermanyEUR
Frankfurt:RHOAFrankfurtGermanyEUR
Dusseldorf:RHODusseldorfGermanyEUR
LS Exchange:A424UKLS ExchangeGermanyEUR
Stuttgart:RHOStuttgartGermanyEUR
VIE:ROGPViennaAustriaEUR
Frankfurt:RHO6FrankfurtGermanyEUR
Munich:RHOMunichGermanyEUR
BMV:ROP1NBMVMexicoMXN
Frankfurt:RHO1FrankfurtGermanyEUR
Hamburg:RHOHamburgGermanyEUR
Hamburg:RHOAHamburgGermanyEUR
Hanover:RHOHanoverGermanyEUR
LS Exchange:891106LS ExchangeGermanyEUR
Turquoise:ROZTurquoiseUnited KingdomCHF
Stuttgart:RHOAStuttgartGermanyEUR
Dusseldorf:RHOADusseldorfGermanyEUR
Lang & Schwarz:891106Lang & SchwarzGermanyEUR
Munich:RHOAMunichGermanyEUR
Turquoise:ROPZTurquoiseUnited KingdomCHF
Dusseldorf:RHO6DusseldorfGermanyEUR
Frankfurt:RHO0FrankfurtGermanyEUR

Log in to ask 6ix AI your own questions about Roche Holding Ltd.